HTA308 Market Access for Anti-Cancer Drugs: Is the Demonstration of a Clinical Benefit on Survival Correlated With Price Level?
Dec 1, 2023, 00:00
10.1016/j.jval.2023.09.1991
https://www.valueinhealthjournal.com/article/S1098-3015(23)05121-5/fulltext
Title :
HTA308 Market Access for Anti-Cancer Drugs: Is the Demonstration of a Clinical Benefit on Survival Correlated With Price Level?
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)05121-5&doi=10.1016/j.jval.2023.09.1991
First page :
Section Title :
Open access? :
No
Section Order :
11444